UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported) September 5, 2006

                 ADVANCED MAGNETICS, INC.                 

(Exact Name of Registrant as Specified in Its Charter)

                               Delaware                               

(State or Other Jurisdiction of Incorporation)

                 0-14732                 
(Commission File Number)

                    04-2742593                    
(IRS Employer Identification No.)

125 Cambridge Park Drive, 6thFloor
          Cambridge, Massachusetts          
(Address of Principal Executive Offices)


               02140               
(Zip Code)

 

                                  (617) 498-3300                                  

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


ITEM 8.01.

OTHER EVENTS.

 

On September 5, 2006, Advanced Magnetics, Inc. (the “Company”) issued a press release regarding the completion of enrollment in two of the Company’s four multi-center Phase III clinical studies of ferumoxytol as an intravenous (IV) iron replacement therapeutic for the treatment of anemia in chronic kidney disease patients, whether or not on dialysis. The Company’s press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.

 

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)

Exhibits.

 

The Company hereby files the following exhibit:

 

 

99.1

Press release dated September 5, 2006.

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADVANCED MAGNETICS, INC.

By: /s/ Jerome Goldstein

 

Name:

Jerome Goldstein

 

Title:

Chief Executive Officer

 

 

 

Date: September 5, 2006

 

 


 

 

Exhibit Index

Exhibit Number
99.1

Description
Press release dated September 5, 2006